查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014836

静脉输液装置市场：按装置类型、技术、应用和最终用户分類的全球市场预测 – 2026-2032 年

Intravenous System Access Devices Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，静脉输液装置市场价值将达到 51.3 亿美元，到 2026 年将成长至 54.7 亿美元，到 2032 年将达到 81.2 亿美元，复合年增长率为 6.75%。

主要市场统计数据
基准年 2025 51.3亿美元
预计年份：2026年 54.7亿美元
预测年份 2032 81.2亿美元
复合年增长率 (%) 6.75%

背景说明解释了影响静脉通路装置引入和创新的临床、操作和监管因素。

静脉通路装置是现代临床护理的基石，可在多种治疗和诊断中实现持续的血管通路。本分析涵盖了旨在满足各种临床需求的中心静脉和周边静脉通路解决方案，从短期復苏到长期静脉输液治疗和家庭护理。随着临床方案的日益完善，医疗专业人员和采购团队越来越需要兼具安全性、易用性和与不断发展的护理路径相容性的装置。

分析临床、技术和供应链趋势的融合，这些趋势正在重塑整个医疗保健领域的设备设计和部署流程以及筹资策略。

静脉通路装置市场正经历一场变革性的重组，其驱动因素包括临床、技术和经济等多面向因素的交织。材料和整合安全技术的进步，正从渐进式改进转向平台层面的提升，优先考虑封闭系统的完整性、连接器标准化以及无针通路，从而降低感染风险。这些技术变革与日益重视以使用者为中心的设计理念相辅相成，降低了手术复杂性，并促进了在非急性照护环境中的应用。

重点评估医疗设备关税政策的变化如何影响采购决策、製造地和策略供应链调整。

贸易政策和关税趋势对医疗设备供应链的影响日益加剧，筹资策略和成本结构也因此受到更多关注。关税措施的实施或调整会波及原料采购、零件进口和成品定价，迫使製造商重新评估与供应商和物流系统的合约。对于静脉输液装置而言，由于其通常依赖来自世界各地的聚合物组件、精密製造和灭菌服务，即使关税负担略有增加，也会促使製造商重新考虑地理布局和与供应商的关係。

将设备架构、技术、临床应用和最终用户背景连结起来的综合細項分析揭示了产品的适用性和商业化重点。

一套精细的细分框架清楚地展现了临床需求、技术和医疗环境之间的交集，从而指导医疗设备的选择并优先考虑创新。从医疗设备类型来看，市场可分为中心静脉通路及週边静脉通路两大类。中心静脉通路包括植入式装置、非隧道式导管、周边置入的中央静脉导管以及隧道式/带套中央静脉导管，每种导管都针对不同的治疗时间和风险状况进行了优化。週边通路包括中线导管和周边静脉导管。这些导管越来越多地应用于门诊和居家医疗环境中，因为在这些环境中，导管的插入和维护便利性至关重要，它们适用于短期至中期治疗。

区域分析比较了美洲、欧洲、中东和非洲以及亚太地区的采购趋势、监管重点和临床引入模式。

区域趋势对整体市场临床应用、监管流程和商业策略有显着影响。在美洲，医疗服务提供者面临着来自私人和公共保险公司的复杂支付体系、高手术量以及完善的门诊医疗基础设施等挑战，这些因素共同推动了对性能可靠、工作流程精简且符合严格安全标准的医疗器械的需求。在该地区，买家通常优先考虑那些展现出明确临床价值和营运效率，并拥有完善的报销管道和成熟分销网络的产品。

评估市场领导地位和产品长期生存能力的竞争定位、创新路径和策略伙伴关係。

静脉通路装置市场的竞争动态透过差异化的产品系列、策略伙伴关係以及对技术和製造的定向投资而清晰可见。主要企业通常会在其核心产品线之外，推出一系列创新产品，例如提升相容性并降低手术复杂性的整合固定係统、抗菌材料以及连接器标准化倡议。此外，为了满足临床医生的偏好和应对报销压力，各公司正在拓展服务范围，提供培训、部署协助和远端监测等支持，旨在降低併发症发生率，并在真实的临床环境中验证产品性能。

一套切实可行的策略行动方案，旨在帮助製造商和医疗保健系统将创新、供应链韧性、证据产生和商业性实施与实用化相结合。

产业领导企业应推动协作，将产品创新、营运韧性和临床价值验证结合。首先，他们必须优先考虑透过整合封闭式系统功能和固定机制来降低感染风险和手术复杂性的设计，同时确保与现有连接器和输注标准的兼容性。其次，他们应制定兼顾成本效益和供应链韧性的生产策略。具体而言，这包括实现组件来源多元化、认证区域生产合作伙伴以及维持储备库存，以确保即使在中断期间也能保证临床供应的连续性。

对混合方法研究途径进行透明的解释，该方法整合了来自临床医生的初步发现、二级监管和技术审查以及供应链映射。

为确保研究的严谨性和实用性，本分析所依据的研究结合了结构化的初步调查、全面的二次文献综述以及系统级供应链映射。初步调查包括对急诊和门诊环境中的临床医生、采购经理、监管专家和医疗设备工程师的访谈，旨在收集有关器械性能、应用障碍和工作流程整合的第一手资料。基于这些访谈，我们对真实临床实践中的关键产品属性和应用驱动因素进行了定性优先排序。

简要总结结论，重点强调临床优先事项、监管准备和供应链韧性是静脉通路装置。

总而言之，静脉通路装置仍然是现代医疗服务的重要组成部分，其发展演变反映了医疗服务向门诊治疗、感染预防和弹性供应链方向转变的趋势。目前，临床实务优先考虑兼具安全性、易用性和在不同医疗环境中适用性的装置，而製造商则面临着对实证医学、法规遵循和营运连续性日益增长的期望。因此，成功的关键在于将产品创新与实际临床工作流程和采购实际情况结合。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 静脉输液装置市场：依装置类型划分

  • 中心静脉通路
    • 嵌入式装置
    • 非隧道导管
    • 周边置入的中央静脉导管
    • 隧道式袖中央静脉导管
  • 週边静脉通路
    • 中线导管
    • 週边静脉导管

第九章：静脉输液装置市场：依技术划分

  • 封闭式系统
  • 整合系统
  • 开放系统

第十章 静脉输液装置市场：依应用领域划分

  • 输血
  • 诊断测试
  • 药物管理
  • 静脉输液和营养支持

第十一章 静脉输液装置市场：依最终用户划分

  • 门诊手术中心
  • 居家医疗及长期照护机构
  • 医院和诊所

第十二章 静脉输液装置市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 静脉输液装置市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 静脉输液装置市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国静脉输液装置市场

第十六章：中国静脉输液装置市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Access Vascular, Inc.
  • Angiplast Private Limited
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Delta Med SpA
  • Disposafe Health and Life Care Ltd.
  • FAS United Medical Company
  • Fresenius SE & Co. KGaA
  • Hangzhou Fushan Medical Appliances Co., LTD.
  • Harsoria Healthcare Pvt Ltd
  • IV Access Technology, Inc.
  • ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • Kimal PLC
  • Medilivescare Manufacturing Private Limited
  • Medivac Surgical Pvt. Ltd.
  • Medtronic PLC
  • Narang Medical Limited
  • Ningbo GreatCare Trading Co., Ltd.
  • Nipro Corporation
  • Poly Medicure Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS
Product Code: MRR-43127F7279F2

The Intravenous System Access Devices Market was valued at USD 5.13 billion in 2025 and is projected to grow to USD 5.47 billion in 2026, with a CAGR of 6.75%, reaching USD 8.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.13 billion
Estimated Year [2026] USD 5.47 billion
Forecast Year [2032] USD 8.12 billion
CAGR (%) 6.75%

A contextual introduction that explains the clinical, operational, and regulatory drivers shaping adoption and innovation in vascular access devices

Intravenous system access devices constitute a foundational element of contemporary clinical care, enabling sustained vascular access for a broad spectrum of therapies and diagnostics. The devices covered in this analysis span central and peripheral vascular access solutions designed to meet diverse clinical requirements, from short-term resuscitation to long-term infusion and home-based therapies. As clinical protocols have grown more sophisticated, practitioners and procurement teams increasingly demand devices that combine safety features, ease of use, and compatibility with evolving care pathways.

This report opens by situating these devices within the broader clinical and operational context. It examines how demographic shifts, rising chronic disease prevalence, expanded outpatient care, and the migration of complex therapies to ambulatory and home settings have altered device utilization patterns. Regulatory scrutiny and infection prevention priorities remain central drivers of product design and procurement choices. Consequently, manufacturers have concentrated on materials science, integrated safety, and workflow-oriented innovations to reduce complications and streamline clinical procedures.

Transitioning from context to strategic priorities, the introduction clarifies the report's scope and analytical framework. It outlines the device categories and technological classifications under review, explains the clinical applications considered, and summarizes the methodological approach used to evaluate suppliers, clinical adoption barriers, and regulatory dynamics that shape product lifecycles.

An analysis of converging clinical, technological, and supply chain trends that are reshaping device design adoption pathways and procurement strategies across care settings

The intravenous access device landscape has entered a period of transformative realignment driven by converging clinical, technological, and economic forces. Advances in materials and integrated safety technologies have moved beyond incremental improvements toward platform-level enhancements that prioritize closed-system integrity, connector standardization, and needleless access to reduce infection risk. These technological shifts coincide with a growing emphasis on user-centered design that lowers procedure complexity and supports adoption across settings beyond the acute hospital.

Meanwhile, clinical practice patterns are evolving. The expansion of outpatient infusion therapies and the acceleration of home healthcare programs have created new demand signals for midline and peripherally inserted devices that balance duration of therapy with insertion safety and ease of maintenance. Regulatory agencies have increased focus on post-market surveillance and device traceability, prompting manufacturers to invest in labeling, unique device identification, and quality systems that facilitate rapid corrective action when needed. In parallel, supply chain resilience has become a strategic priority; stakeholders are diversifying suppliers and reshoring critical manufacturing steps to mitigate disruption risk.

Taken together, these shifts demand that companies align R&D, manufacturing, and commercial models to support cross-setting care, integrate safety and connectivity features, and deliver systems that fit both clinician workflows and patient-centered care pathways.

A focused evaluation of how evolving tariff policies are influencing sourcing decisions manufacturing footprints and strategic supply chain adjustments for medical devices

Trade policy and tariff dynamics affecting medical device supply chains have intensified scrutiny of sourcing strategies and cost structures. When tariff measures are applied or adjusted, they transmit through raw material procurement, component imports, and finished device pricing, prompting manufacturers to reassess vendor contracts and logistics arrangements. For intravenous access devices, which often rely on polymer components, precision manufacturing, and sterilization services sourced globally, any incremental tariff burden increases the incentive to re-evaluate geographic footprints and supplier relationships.

Consequently, stakeholders have undertaken scenario planning to understand cumulative cost exposure, timing of tariff implementation, and mitigation pathways such as localizing production, qualifying alternative suppliers, or redesigning products to reduce dependence on tariff-sensitive inputs. Transitional impacts include renegotiated supplier contracts, phased inventory adjustments, and greater emphasis on supply chain visibility to prevent margin erosion while preserving product availability for clinicians and patients.

Importantly, the operational response to tariff-driven pressure does not occur in isolation. Regulatory compliance, quality oversight, and time-to-market constraints shape the feasibility and pace of supply chain shifts. As a result, many firms prioritize a hybrid approach that combines nearshoring for critical components with diversified global sourcing for commoditized inputs, while employing contractual and operational hedges to maintain continuity and manage financial exposure.

A comprehensive segmentation synthesis linking device architectures technologies clinical applications and end-user contexts to illuminate product fit and commercialization priorities

A nuanced segmentation framework clarifies where clinical need, technology, and care setting intersect to shape device selection and innovation priorities. By device type, markets separate into central intravenous access and peripheral intravenous access categories. Central options encompass implantable devices, non-tunneled catheters, peripherally inserted central catheters, and tunneled and cuffed central catheters, each optimized for differing duration of therapy and risk profiles. Peripheral access includes midline catheters and peripheral intravenous catheters, which address short- to intermediate-duration therapies and are increasingly used in ambulatory and home settings where ease of insertion and maintenance are critical.

From a technology standpoint, devices cluster into closed systems, integrated systems, and open systems. Closed systems emphasize infection prevention through sealed pathways, integrated systems combine multiple functional elements such as securement and access management into unified platforms, and open systems prioritize modularity and interchangeability. These technological distinctions drive procurement choices depending on clinical priorities, interoperability requirements, and staff training considerations.

The application dimension captures how clinical use cases influence device specification, covering blood transfusion, diagnostic testing, drug administration, and fluid and nutritional support. Each application poses different flow, compatibility, and dwell-time demands that inform product selection and procedural protocols. Finally, end-user segmentation distinguishes ambulatory surgical centers, homecare settings and long-term care facilities, and hospitals and clinics, recognizing that device features and packaging must align with the capabilities and workflows of each care environment. Together, these segmentation lenses provide a practical structure for evaluating product fit, development priorities, and commercialization strategies.

A regional analysis that contrasts procurement dynamics regulatory priorities and clinical adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics materially influence clinical adoption, regulatory pathways, and commercial strategies across the market. In the Americas, healthcare providers navigate a complex mix of private and public payers, high procedural volumes, and robust outpatient care infrastructure, driving demand for devices that deliver reliable performance, streamlined workflows, and compliance with stringent safety standards. In this region, purchasers often prioritize products that demonstrate clear clinical value and operational efficiencies, supported by strong reimbursement pathways and established distribution networks.

In Europe, the Middle East and Africa, regulators emphasize harmonized safety standards, while health systems vary widely in procurement sophistication and budgetary constraints. Stakeholders in this region balance affordability with compliance, and they increasingly adopt technologies that demonstrate reduced complication rates and lower total cost of care. In addition, private-sector growth and public health investments create opportunities for product differentiation based on quality and post-market support.

Across Asia-Pacific, rapid modernization of healthcare infrastructure, expanding access to outpatient and homecare services, and domestic manufacturing ambitions shape a dynamic competitive landscape. Manufacturers pursuing this region prioritize scalable production models, regulatory engagement, and adaptations for local clinical practices and procurement mechanisms. Collectively, these regional patterns require manufacturers to customize go-to-market approaches, regulatory strategies, and supply chain footprints to align with each area's clinical priorities and operational realities.

An assessment of competitive positioning innovation pathways and strategic partnerships that determine market leadership and long-term product viability

Competitive dynamics in the intravenous access device market manifest through differentiated portfolios, strategic partnerships, and targeted investments in technology and manufacturing. Leading organizations typically balance core product lines with adjacent innovations such as integrated securement systems, antimicrobial materials, and connector standardization initiatives that facilitate compatibility and reduce procedural complexity. In response to clinician preferences and reimbursement pressures, companies have also extended services that support training, adoption, and remote monitoring to reduce complication rates and demonstrate real-world performance.

Mergers and strategic alliances remain a common pathway for acquiring capability in materials science, sterilization technologies, and closed-system engineering. Concurrently, smaller specialized firms often focus on niche clinical problems or platform innovations that larger manufacturers selectively acquire or license. Transitioning from R&D to scale requires robust quality systems and regulatory acumen, so many companies invest in regional manufacturing and regulatory affairs capabilities to accelerate approvals and local market access.

Supply chain resilience and cost control also shape competitive positioning. Firms that secure diversified, quality-assured supply bases and invest in redundancy enjoy greater flexibility during disruption. Ultimately, market leadership accrues to organizations that combine clinical evidence generation, user-centered design, scalable manufacturing, and commercial models that align with care delivery trends across multiple settings.

A pragmatic set of strategic actions for manufacturers and health systems to align innovation supply chain resilience evidence generation and commercial execution for meaningful adoption

Industry leaders should pursue a coordinated agenda that aligns product innovation with operational resilience and clinical value demonstration. First, prioritize designs that reduce infection risk and procedural complexity by integrating closed-system features and securement mechanisms, while ensuring compatibility with prevailing connector and infusion standards. Second, deploy manufacturing strategies that balance cost efficiency with supply chain resilience; diversify component sourcing, qualify regional production partners, and develop contingency inventories to sustain clinical supply continuity during disruptions.

Third, invest in evidence generation that demonstrates real-world outcomes across hospitals, ambulatory surgical centers, and homecare environments. Transitional adoption often depends on case studies and pilot programs that document reduced complications, shortened procedure times, or lower total care costs. Fourth, strengthen regulatory and post-market surveillance capabilities to accelerate approvals and to respond rapidly to safety signals. Fifth, cultivate commercial models that include clinician training, onboarding support, and service offerings that lower the barrier to adoption in non-hospital settings.

By executing on these priorities in a coordinated manner, companies can improve product-market fit, minimize operational risks associated with trade or supply interruptions, and create durable competitive advantages grounded in clinical impact and operational reliability.

A transparent description of the mixed-methods research approach that integrates primary clinician insights secondary regulatory and technical review and supply chain mapping

The research underpinning this analysis combines structured primary engagements, comprehensive secondary review, and systems-level supply chain mapping to ensure rigor and applicability. Primary research included interviews with clinicians across acute and outpatient settings, procurement leaders, regulatory specialists, and device engineers to capture experiential insights on device performance, adoption barriers, and workflow integration. These discussions informed qualitative prioritization of product attributes and adoption levers that matter in real-world settings.

Secondary research synthesized regulatory guidance, clinical practice recommendations, peer-reviewed literature, and publicly available technical specifications to validate product classifications and to understand safety and performance expectations. Supply chain analysis mapped typical component flows for polymer-based catheters, connectors, and sterilization services, highlighting points of concentration and potential bottlenecks. The methodological approach employed cross-validation between primary and secondary sources, thematic coding of interview responses, and triangulation of technological trends with regulatory trajectories.

To ensure reliability, the research team documented assumptions, reviewed alternative scenarios for policy and trade shifts, and conducted sensitivity checks on operational implications. The result is a defensible, action-oriented synthesis that connects clinical priorities to product attributes and strategic imperatives for manufacturers and health systems.

A concise concluding synthesis that emphasizes clinical priorities regulatory readiness and supply chain resilience as the pillars of strategic success in vascular access devices

In closing, intravenous access devices remain a critical enabler of modern care delivery, and their evolution reflects broader shifts toward outpatient therapies, infection prevention, and resilient supply chains. Clinical demand now prioritizes devices that combine safety, ease of use, and cross-setting applicability, while manufacturers face intensifying expectations for evidence, regulatory compliance, and operational continuity. Consequently, success depends on aligning product innovation with real-world clinical workflows and procurement realities.

Looking ahead, stakeholders who invest in integrated safety features, regional manufacturing flexibility, and robust post-market evidence will be best positioned to meet clinician needs and to navigate regulatory and trade complexities. Moreover, partnerships that accelerate training, streamline adoption, and provide real-world performance data will create tangible differentiation in procurement conversations. As healthcare delivery models continue to decentralize, the firms that translate clinical insight into practical, reliable device systems will capture the most durable opportunities.

Overall, the market presents significant strategic choices; by emphasizing clinical impact, supply chain resilience, and disciplined evidence generation, organizations can deliver meaningful improvements in patient care while building sustainable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous System Access Devices Market, by Device Type

  • 8.1. Central Intravenous Access
    • 8.1.1. Implantable Devices
    • 8.1.2. Non-tunneled Catheters
    • 8.1.3. Peripherally Inserted Central Catheter
    • 8.1.4. Tunneled & Cuffed Central Catheter
  • 8.2. Peripheral Intravenous Access
    • 8.2.1. Midline Catheter
    • 8.2.2. PIV Catheter

9. Intravenous System Access Devices Market, by Technology

  • 9.1. Closed System
  • 9.2. Integrated System
  • 9.3. Open System

10. Intravenous System Access Devices Market, by Application

  • 10.1. Blood Transfusion
  • 10.2. Diagnostic Testing
  • 10.3. Drug Administration
  • 10.4. Fluid & Nutritional Support

11. Intravenous System Access Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare Settings & Long-term Care Facilities
  • 11.3. Hospitals & Clinics

12. Intravenous System Access Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intravenous System Access Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intravenous System Access Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Intravenous System Access Devices Market

16. China Intravenous System Access Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Access Vascular, Inc.
  • 17.6. Angiplast Private Limited
  • 17.7. Argon Medical Devices, Inc.
  • 17.8. B. Braun SE
  • 17.9. Baxter International Inc.
  • 17.10. Becton, Dickinson and Company
  • 17.11. Delta Med S.p.A.
  • 17.12. Disposafe Health and Life Care Ltd.
  • 17.13. FAS United Medical Company
  • 17.14. Fresenius SE & Co. KGaA
  • 17.15. Hangzhou Fushan Medical Appliances Co., LTD.
  • 17.16. Harsoria Healthcare Pvt Ltd
  • 17.17. I-V Access Technology, Inc.
  • 17.18. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • 17.19. Kimal PLC
  • 17.20. Medilivescare Manufacturing Private Limited
  • 17.21. Medivac Surgical Pvt. Ltd.
  • 17.22. Medtronic PLC
  • 17.23. Narang Medical Limited
  • 17.24. Ningbo GreatCare Trading Co., Ltd.
  • 17.25. Nipro Corporation
  • 17.26. Poly Medicure Limited
  • 17.27. Teleflex Incorporated
  • 17.28. Terumo Corporation
  • 17.29. Vygon SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 152. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 159. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)